Jack A. Kauffman

1.1k total citations
30 papers, 853 citations indexed

About

Jack A. Kauffman is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Jack A. Kauffman has authored 30 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Hematology and 7 papers in Organic Chemistry. Recurrent topics in Jack A. Kauffman's work include Chemical Synthesis and Analysis (10 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Jack A. Kauffman is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Jack A. Kauffman collaborates with scholars based in United States and Japan. Jack A. Kauffman's co-authors include Patricia Andrade‐Gordon, Bruce E. Maryanoff, Michael N. Greco, Michael J. Costanzo, Han‐Cheng Zhang, Harold R. Almond, Stephen C. Yabut, Lawrence de Garavilla, Bruce P. Damiano and Barbara J. Haertlein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Jack A. Kauffman

30 papers receiving 805 citations

Peers

Jack A. Kauffman
Robert A. Galemmo United States
Bertrand Leblond France
Giang T. Le Australia
Michael N. Greco United States
GR Pettit United States
Bruce E. Tomczuk United States
Carl Crysler United States
Kirk Robarge United States
Karl F. Erhard United States
Christine Lambert‐van der Brempt United Kingdom
Robert A. Galemmo United States
Jack A. Kauffman
Citations per year, relative to Jack A. Kauffman Jack A. Kauffman (= 1×) peers Robert A. Galemmo

Countries citing papers authored by Jack A. Kauffman

Since Specialization
Citations

This map shows the geographic impact of Jack A. Kauffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack A. Kauffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack A. Kauffman more than expected).

Fields of papers citing papers by Jack A. Kauffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack A. Kauffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack A. Kauffman. The network helps show where Jack A. Kauffman may publish in the future.

Co-authorship network of co-authors of Jack A. Kauffman

This figure shows the co-authorship network connecting the top 25 collaborators of Jack A. Kauffman. A scholar is included among the top collaborators of Jack A. Kauffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack A. Kauffman. Jack A. Kauffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kauffman, Jack A. & Nizar Y. Saad. (2023). P65 Development of therapeutic extracellular vesicle enveloped-AAV vectors for muscle gene therapy. Neuromuscular Disorders. 33. S75–S75. 1 indexed citations
2.
Zhang, Xuqing, Bin Zhu, Lili Guo, et al.. (2021). Optimization of physicochemical properties of pyridone-based EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 47. 128172–128172. 4 indexed citations
3.
Zhang, Xuqing, Bin Zhu, Lili Guo, et al.. (2021). Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters. 12(3). 451–458. 4 indexed citations
4.
Greco, Michael N., Mark J. Macielag, Christopher A. Teleha, et al.. (2018). 6-Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB1) Receptor Inverse Agonists and Chemical Modifications for Peripheral Selectivity. Journal of Medicinal Chemistry. 61(22). 10276–10298. 12 indexed citations
5.
Zhang, Xuqing, Zhihua Sui, Jack A. Kauffman, et al.. (2017). Evaluation of anti-diabetic effect and gall bladder function with 2-thio-5-thiomethyl substituted imidazoles as TGR5 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 27(8). 1760–1764. 14 indexed citations
6.
Zhang, Xuqing, Mark J. Wall, Zhihua Sui, et al.. (2017). Discovery of Orally Efficacious Tetrahydrobenzimidazoles as TGR5 Agonists for Type 2 Diabetes. ACS Medicinal Chemistry Letters. 8(5). 560–565. 9 indexed citations
7.
Zhang, Sui‐Po, Jack A. Kauffman, Susan K. Yagel, & Ellen E. Codd. (2006). High-Throughput Screening for N-Type Calcium Channel Blockers Using a Scintillation Proximity Assay. SLAS DISCOVERY. 11(6). 672–677. 10 indexed citations
8.
Garavilla, Lawrence de, Michael N. Greco, N. Sukumar, et al.. (2005). A Novel, Potent Dual Inhibitor of the Leukocyte Proteases Cathepsin G and Chymase. Journal of Biological Chemistry. 280(18). 18001–18007. 75 indexed citations
9.
Hong, Xin, Alejandro Bernal, Albert Pinhasov, et al.. (2004). High-Throughput siRNA-Based Functional Target Validation. SLAS DISCOVERY. 9(4). 286–293. 18 indexed citations
10.
Pinhasov, Albert, Jay Mei, Dhammika Amaratunga, et al.. (2004). Gene Expression Analysis for High Throughput Screening Applications. Combinatorial Chemistry & High Throughput Screening. 7(2). 133–140. 10 indexed citations
11.
Costanzo, Michael J., Stephen C. Yabut, Harold R. Almond, et al.. (2003). Potent, Small-Molecule Inhibitors of Human Mast Cell Tryptase. Antiasthmatic Action of a Dipeptide-Based Transition-State Analogue Containing a Benzothiazole Ketone. Journal of Medicinal Chemistry. 46(18). 3865–3876. 67 indexed citations
12.
Damiano, Bruce P., John A. Mitchell, Edward C. Giardino, et al.. (2001). Antiplatelet and Antithrombotic Activity of RWJ-53308, A Novel Orally Active Glycoprotein IIb/IIIa Antagonist. Thrombosis Research. 104(2). 113–126. 26 indexed citations
13.
Lawson, Edward C., William J. Hoekstra, Marylyn M. Addo, et al.. (2001). 1,2,4-Triazolo[3,4-a]pyridine as a novel, constrained template for fibrinogen receptor (GPIIb/IIIa) antagonists. Bioorganic & Medicinal Chemistry Letters. 11(19). 2619–2622. 47 indexed citations
14.
Kanojia, Ramesh M., Joseph J. Salata, & Jack A. Kauffman. (2000). Synthesis and class III type antiarrhythmic activity of 4-aroyl (and aryl)-1-aralkylpiperazines. Bioorganic & Medicinal Chemistry Letters. 10(24). 2819–2823. 7 indexed citations
15.
Hoekstra, William J., David F. McComsey, Patricia Andrade‐Gordon, et al.. (1998). Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motif. Bioorganic & Medicinal Chemistry Letters. 8(13). 1649–1654. 29 indexed citations
16.
Greco, Michael N., Leonard R. Hecker, Patricia Andrade‐Gordon, et al.. (1996). Novel thrombin inhibitors that are based on a macrocyclic tripeptide motif. Bioorganic & Medicinal Chemistry Letters. 6(24). 2947–2952. 14 indexed citations
17.
Maryanoff, Bruce E., et al.. (1995). Cyclotheonamide derivatives: Synthesis and thrombin inhibition. Exploration of specific structure-function issues. Bioorganic & Medicinal Chemistry. 3(8). 1025–1038. 23 indexed citations
18.
Maryanoff, Bruce E., Michael N. Greco, Han‐Cheng Zhang, et al.. (1995). Macrocyclic Peptide Inhibitors of Serine Proteases. Convergent Total Synthesis of Cyclotheonamides A and B via a Late-Stage Primary Amine Intermediate. Study of Thrombin Inhibition under Diverse Conditions. Journal of the American Chemical Society. 117(4). 1225–1239. 70 indexed citations
19.
Maryanoff, Bruce E., Xiayang Qiu, K. Padmanabhan, et al.. (1993). Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A.. Proceedings of the National Academy of Sciences. 90(17). 8048–8052. 90 indexed citations
20.
Press, Jeffery B., Robert Falotico, Zoltan G. Hajos, et al.. (1992). Synthesis and structure-activity relationship of 6-substituted purine derivatives as novel selective positive inotropes. Journal of Medicinal Chemistry. 35(24). 4509–4515. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert A. Galemmo Breakdown of academic impact, for papers by Bertrand Leblond Breakdown of academic impact, for papers by Giang T. Le Breakdown of academic impact, for papers by Michael N. Greco Breakdown of academic impact, for papers by GR Pettit Breakdown of academic impact, for papers by Bruce E. Tomczuk Breakdown of academic impact, for papers by Carl Crysler Breakdown of academic impact, for papers by Kirk Robarge Breakdown of academic impact, for papers by Karl F. Erhard Breakdown of academic impact, for papers by Christine Lambert‐van der Brempt
Rankless by CCL
2026